Embed Size (px)
Citation preview
ABSTRACTS
model, very far from a "real" experimentbut it has a rational hypothesis that has nowbeen tested and "proved" with this mathematical model. Although the introductionsection correctly points out that such amodel is "independent of the many confounding factors present in laboratory studIes and in clinical trials, " those sameconfounders will be present in the field aswell. This IS the difference between efficacyresearch, which this article almost IS, andeffectIVeness research. Whether theimproved perfusion that is theoretically possible with these technique variatIOns willtranslate into clinical benefit has not yetbeen adequately proved although the mostrecent study by Plaisance et afl IS fairly convincing.
D. C Cone, MD
1 PlaIsance P. Lune KG, VIcaUt E, et al A wmpamon ofstandard cardIOpulmonary resusCltatwn and active wmpresswn-decompre'Swn resusCltatwn jor out-oj-hospitalcardwc arrest French ActIve CompresslOn-Decompn~'iqon
CardIOpulmonary ResusCltatwn Study Group N Engl JMeu 1999.341 569-575
AUGUST 2000 362 ANNALS OF EMERGENCY MEDICINE
BTLS Research Task ForceCall forAbstracts
Abstract Submission Deadline: September 15, 2000BTlS International Trauma Conference 2000
November9-11, 2000Westminster, Colorado
The BTLS International Research Task Force IS accepting abstracts for poster presentations attheBTLS International Trauma Conference In Colorado In the fall of 2000 Original work involving allaspects oftrauma care and related EMS Issues Will be conSidered
All abstracts will be reviewed and scored In ablinded fashion by members ofthe BTLS InternatIOnalResearch Task Force The exact number of papers accepted will be determined by the time andspace limitations atthe conference Research submitted for consideratIOn may not have been published previously, although submission of abstracts, which have been presented at other meetings,IS permissible An abstract form can be obtained from BTLS International
Submission rules
• Abstracts must be typed double-spaced and must be less than 300 words In length
• To ensure blinding, do not Include any Identifying information In the abstract ThiS Includes the
names of Institutions and authors
• Tables may be used and may be single-spaced No Illustrations or references are permitted In
the abstract
• All studies involving human subjects must state that they meetthe requirements governingInformed consent
• Abstracts must use the structured abstract format as follows
Objective ThiS IS aprecise statement ofthe purpose of the study or the pre-study hypotheSIS
Other brief Introductory material may be Included.
2 Methods Give abrief deSCription ofthe methods used, Including Information aboutthat study
deSign, participants/subJects, setting, interventIOns/observations, and measurements as
relevant The purpose of the Methods section IS to prOVide sufficient details to demonstrate
how the study was carried out
3 Results Asummary of the results should be presented In suffiCient detail to support the con
clUSions The statistical methods used should be mentioned In thiS section
4 ConclUSions Succinctly state concl us Ions firmly supported by the data presented Include
Important limitations If appropriate
SubmiSSions must be received by September 15, 2000, for conSideration forthe 2000 conferenceAuthors of abstracts will receive notification of acceptance or rejection by October 1,2000Questions can be directed to BTLS InternatIOnal at 800-495-BTLS (United States and Canada) or630-495-6442 (internationally) or on the Web site atwww btls org
1 75
